Fulgent Genetics, Inc. Annual Income Tax Expense (Benefit) in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Fulgent Genetics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2014 to 2023.
  • Fulgent Genetics, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was -$3.84M, a 119% decline year-over-year.
  • Fulgent Genetics, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was -$17.2M, a 752% decline year-over-year.
  • Fulgent Genetics, Inc. annual Income Tax Expense (Benefit) for 2023 was $1.15M, a 97.3% decline from 2022.
  • Fulgent Genetics, Inc. annual Income Tax Expense (Benefit) for 2022 was $42.1M, a 75.9% decline from 2021.
  • Fulgent Genetics, Inc. annual Income Tax Expense (Benefit) for 2021 was $175M, a 141% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.15M -$40.9M -97.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 $42.1M -$133M -75.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 $175M +$102M +141% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $72.5M +$72.5M +168579% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $43K +$7K +19.4% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 $36K +$1.05M Jan 1, 2018 Dec 31, 2018 10-K 2020-03-13
2017 -$1.02M -$1.94M -210% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-22
2016 $920K +$920K Jan 1, 2016 Dec 31, 2016 10-K 2018-03-20
2015 $0 $0 Jan 1, 2015 Dec 31, 2015 10-K 2017-03-17
2014 $0 Jan 1, 2014 Dec 31, 2014 10-K 2017-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.